Tempest Therapeutics Inc (TPST) Clearly Signals Buy-Into the Stock: Don’t ignore the signals

With 0.62 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.31 million shares. The 52-week range on TPST shows that it touched its highest point at $6.00 and its lowest point at $0.70 during that stretch. It currently has a 1-year price target of $18.75. Beta for the stock currently stands at -1.84.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of TPST was down-trending over the past week, with a drop of -6.38%, but this was down by -5.73% over a month. Three-month performance surged to 0.66% while six-month performance fell -41.16%. The stock lost -76.14% in the past year, while it has gained 4.35% so far this year. A look at the trailing 12-month EPS for TPST yields -1.54 with Next year EPS estimates of -1.04. For the next quarter, that number is -0.25. This implies an EPS growth rate of 29.54% for this year and 22.74% for next year. EPS is expected to grow by 12.39% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 62.66%.

Float and Shares Shorts:

At present, 43.64 million TPST shares are outstanding with a float of 39.62 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for TPST since 1 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$1.22958 being high and -$1.42321 being low. For TPST, this leads to a yearly average estimate of -$1.34576. Based on analyst estimates, the high estimate for the next quarter is -$0.25 and the low estimate is -$0.31. The average estimate for the next quarter is thus -$0.28.